2023
DOI: 10.1016/j.cmet.2023.03.004
|View full text |Cite
|
Sign up to set email alerts
|

SUCNR1 signaling in adipocytes controls energy metabolism by modulating circadian clock and leptin expression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 21 publications
(7 citation statements)
references
References 109 publications
0
6
1
Order By: Relevance
“…SUCNR1 activation initiates interaction with heterotrimeric GTPases, thereby stimulating downstream signalling events that vary with cell type, leading to different downstream signals and effects in a cell-dependent manner. Succinate–SUCNR1 signalling has been implicated in various transduction pathways, such as ERK pathways in cardiomyocytes [ 24 ] and AMP-activated protein kinase (AMPK) pathways in adipocytes [ 25 ]. Though the desensitisation and internalisation processes of SUCNR1 are similar to those of other GPCRs, our understanding of these mechanisms remains rudimentary.…”
Section: Succinate: a Dual Metabolite From Multifaceted Perspectives—...mentioning
confidence: 99%
See 1 more Smart Citation
“…SUCNR1 activation initiates interaction with heterotrimeric GTPases, thereby stimulating downstream signalling events that vary with cell type, leading to different downstream signals and effects in a cell-dependent manner. Succinate–SUCNR1 signalling has been implicated in various transduction pathways, such as ERK pathways in cardiomyocytes [ 24 ] and AMP-activated protein kinase (AMPK) pathways in adipocytes [ 25 ]. Though the desensitisation and internalisation processes of SUCNR1 are similar to those of other GPCRs, our understanding of these mechanisms remains rudimentary.…”
Section: Succinate: a Dual Metabolite From Multifaceted Perspectives—...mentioning
confidence: 99%
“…Studies have observed transiently elevated succinate levels during physiological states, like exercise [ 29 ] and food intake [ 30 ], implying additional metabolic functions. In this context, it has been revealed that SUCNR1 signalling contributes to paracrine communication in skeletal muscle during exercise, resulting in muscle remodelling [ 29 ] and controls leptin production by adipose tissue in response to food ingestion [ 25 ]. The transient increase in succinate levels, which appears to be essential for regulating physiological responses to exercise and feeding via SUCNR1, differs notably from the consequences of chronic succinate elevation that are observed in metabolic disorders.…”
Section: Succinate: a Dual Metabolite From Multifaceted Perspectives—...mentioning
confidence: 99%
“…By influencing enzymatic activities, gene expression, and signaling pathways, signal metabolites orchestrate a wide array of physiological responses, spanning from adaptation to stress to the coordination of growth and differentiation [ 5 ]. Succinate, a key metabolite in the tricarboxylic acid cycle, has recently garnered significant attention for its intriguing role in the modulation of WAT physiology [ 60 , 94 ]. Emerging research has unveiled a novel connection between succinate and the conversion of white adipocytes to beige adipocytes, a process known as white-to-beige adipocyte conversion.…”
Section: Mitochondrial Role In Determining White Adipocyte Identitymentioning
confidence: 99%
“…Extracellular succinate is a pleiotropic hormone-like metabolite that acts via its receptor, succinate receptor 1 (SUCNR1) (Fernandez-Veledo et al, 2021; He et al, 2004), that is widely expressed in human tissues (Gilissen et al, 2016) including epithelia of the intestine and kidney (Schneider et al, 2018), white adipose tissue and immunological tissue (Rubic et al, 2008). The close relationship between SUCNR1 and many inflammatory and metabolic diseases such as liver fibrosis (Winther et al, 2021), type 2 diabetes (Villanueva-Carmona et al, 2023), rheumatoid arthritis (Littlewood-Evans et al, 2016), dermatitis (Gnana-Prakasam et al, 2011), cancer metastasis (Wu et al, 2020), obesity (Keiran et al, 2019), and hypertension (Sadagopan et al, 2007), make this receptor an attractive target for therapeutic intervention.…”
Section: Introductionmentioning
confidence: 99%